Detalhe da pesquisa
1.
KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma.
N Engl J Med
; 376(20): 1911-1920, 2017 05 18.
Artigo
Inglês
| MEDLINE | ID: mdl-28514613
2.
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.
Blood
; 123(6): 837-42, 2014 Feb 06.
Artigo
Inglês
| MEDLINE | ID: mdl-24264230
3.
High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.
J Natl Compr Canc Netw
; 14(10): 1274-1281, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27697981
4.
Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project.
Cancer
; 121(7): 1032-9, 2015 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25492236
5.
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.
Cancer
; 120(13): 1993-9, 2014 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24706502
6.
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database.
Br J Haematol
; 163(4): 487-95, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24111533